📰 Leinco Technologies News
Leinco Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leinco Technologies. Real-time updates on events, politics, business and more.
January 11, 2023
Leinco Technologies tests antibody clones available for their ability to bind and visualize mpox virus in cell cultures
December 7, 2022
University of Pittsburgh researcher, Dr. Lawrence Andrews, shares his latest work unraveling the synergistic role of PD-1 and LAG-3 in cancer immune evasion
November 22, 2022
Read this article to discover the latest progress and technological advances in spatial biology for cancer research
November 22, 2022
Read this article to discover the latest progress and technological advances in spatial biology for cancer research
August 31, 2022
In this white paper, Leinco Technologies explores how spatial-omics, especially spatial phenotyping, is revolutionizing translational medicine for the treatment of cancer, and the key role played by high-quality antibodies in the generation of data that is reliable and reproducible.
March 29, 2022
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global ... | March 29, 2022
December 8, 2021
Learn how antibody researchers teamed up with a biologics manufacturer to develop diagnostic tests and treatments for viral infections
December 7, 2021
Learn how antibody researchers teamed up with a biologics manufacturer to develop diagnostic tests and treatments for viral infections
April 15, 2021
Abstract The compelling need to provide adoptive cell therapy (ACT) to an increasing number of oncology patients within a meaningful therapeutic window makes the development of an efficient, fast, versatile, and safe genetic tool for creating recombinant T cells indispensable. In this study, we used nonintegrating minimally sized DNA vectors with an enhanced capability of generating genetically modified cells, and we demonstrate that they can be efficiently used to engineer human T lymphocytes....
March 17, 2021
Special Feature: 10 top new resources to advance your engineered antibody research Explore our exclusive interviews, free downloads, latest methods, and much more to help support your antibody research 16 Mar 2021 As part of our new special feature, we’ve pulled together a selection of the top new resources to aid your work with engineered antibodies. Download our comprehensive guide to optimal antibody selection and application, discover the value of label-free technology for streamlined dru...